Work

Everolimus plus octreotide long-acting release (LAR) for the treatment of advanced neuroendocrine tumors (NET) associated with carcinoid syndrome (RADIANT-2) : Updated overall survival results

Year: 2013

Type: article

Source: European Journal of Cancer

Authors: Anne Couvelard, Kjell E. Öberg, John D. Hainsworth, D. Lam, S. G. Stergiopolos, Nicolas Rouyrre, Marc Peeters, Éric Baudin, D. Gross, James C. Yao

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242870605

FWCI:

Cites:

Cited by: 2

Related to: 10